Amarin Corporation PLC

Change company Symbol lookup

Select an option...

AMRN Amarin Corporation PLC

EWA iShares MSCI Australia ETF

WDAY Workday Inc

BNOX Bionomics Ltd

NRDY Nerdy Inc

KEY KeyCorp

AMPX Amprius Technologies Inc

TPC Tutor Perini Corp

LTRN Lantern Pharma Inc

JGGC Jaguar Global Growth Corporation I

Go

Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

ADR Fees

American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees